Effect of Adjuvant/Neoadjuvant Trastuzumab on Clinical Outcomes in Patients With HER2-Positive Metastatic Breast CancerMURTHY, Rashmi K; VARMA, Ankur; BOOSER, Daniel et al.Cancer. 2014, Vol 120, Num 13, pp 1932-1938, issn 0008-543X, 7 p.Article

A Phase 1 Study of Weekly Everolimus (RAD001) in Combination With Docetaxel in Patients With Metastatic Breast CancerMOULDER, Stacy; GLADISH, Gregory; RIVERA, Edgardo et al.Cancer. 2012, Vol 118, Num 9, pp 2378-2384, issn 0008-543X, 7 p.Article

A Phase I study of docetaxel plus cyclophosphamide in solid tumors followed by a Phase II study as first-line therapy in metastatic breast cancersTRENT, Jonathan C; VALERO, Vicente; CRISTOFANILLI, Massimo et al.Clinical cancer research. 2003, Vol 9, Num 7, pp 2426-2434, issn 1078-0432, 9 p.Article

Phase I trial of intratumoral liposome E1A Gene therapy in patients with recurrent breast and head and neck cancerYOO, George H; HUNG, Mien-Chie; LOPEZ-BERESTEIN, Gabriel et al.Clinical cancer research. 2001, Vol 7, Num 5, pp 1237-1245, issn 1078-0432Article

A Phase 2 Study of a Fixed Combination of Uracil and Ftorafur and Leucovorin Given Orally in a Twice-Daily Regimen to Treat Patients With Recurrent Metastatic Breast CancerHORTOBAGYI, Gabriel N; YOUNG, Robyn R; KARWAL, Mark et al.Cancer. 2010, Vol 116, Num 10, pp 2301-2306, issn 0008-543X, 6 p.Article

Rab9 GTPase is required for replication of human immunodeficiency virus type 1, filoviruses, and measles virusMURRAY, James L; MAVRAKIS, Manos; LIPPINCOTT-SCHWARTZ, Jennifer et al.Journal of virology. 2005, Vol 79, Num 18, pp 11742-11751, issn 0022-538X, 10 p.Article

Yttrium-90 ibritumomab tiuxetan radioimmunotherapy in Richter syndromeTSIMBERIDOU, Apostolia-Maria; MURRAY, James L; O'BRIEN, Susan et al.Cancer. 2004, Vol 100, Num 10, pp 2195-2200, issn 0008-543X, 6 p.Article

Phase I and II study of exisulind in combination with capecitabine in patients with metastatic breast cancerPUSZTAI, Lajos; JIM HOU ZHEN; BOOSER, Daniel et al.Journal of clinical oncology. 2003, Vol 21, Num 18, pp 3454-3461, issn 0732-183X, 8 p.Article

Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor―positive metastatic breast cancerESTEVA, Francisco J; MOULDER, Stacy L; GONZALEZ-ANGULO, Ana M et al.Cancer chemotherapy and pharmacology. 2013, Vol 71, Num 1, pp 63-72, issn 0344-5704, 10 p.Article

Results of the First Phase I Clinical Trial of the Novel Ii-Key Hybrid Preventive HER-2/neu Peptide (AE37) VaccineHOLMES, Jarrod P; BENAVIDES, Linda C; PONNIAH, Sathibalan et al.Journal of clinical oncology. 2008, Vol 26, Num 20, pp 3426-3433, issn 0732-183X, 8 p.Article

Rab 5 is required for the cellular entry of dengue and west nile virusesKRISHNAN, Manoj N; SUKUMARAN, Bindu; PAL, Utpal et al.Journal of virology. 2007, Vol 81, Num 9, pp 4881-4885, issn 0022-538X, 5 p.Article

Prostate tumor cells infected with a recombinant influenza virus expressing a truncated NS1 protein activate cytolytic CD8⁺ cells to recognize noninfected tumor cellsEFFERSON, Clay L; TSUDA, Naotake; KAWANO, Kouichiro et al.Journal of virology. 2006, Vol 80, Num 1, pp 383-394, issn 0022-538X, 12 p.Article

Stimulation of cells from a non-invaded and an invaded lymph node with a HER-2⁺ tumor with peptides corresponding to T-cell epitopes E75 and G89 induced expansion of central memory cells (TCM) from the metastasis-negative lymph nodesKO, Byung K; EFFERSON, Clay L; KAWANO, Kouichiro et al.International journal of oncology. 2004, Vol 24, Num 6, pp 1413-1418, issn 1019-6439, 6 p.Article

Toxicity, immunogenicity, and induction of E75-specific tumor-lytic CTLs by HER-2 peptide E75 (369-377) combined with granulocyte macrophage colony-stimulating factor in HLA-A2+ patients with metastatic breast and ovarian cancerMURRAY, James L; GILLOGLY, Michael E; IOANNIDES, Constantin G et al.Clinical cancer research. 2002, Vol 8, Num 11, pp 3407-3418, issn 1078-0432, 12 p.Article

Prognostic value of single nucleotide polymorphisms of candidate genes associated with inflammation in early stage breast cancerMURRAY, James L; THOMPSON, Patricia; SUK YOUNG YOO et al.Breast cancer research and treatment. 2013, Vol 138, Num 3, pp 917-924, issn 0167-6806, 8 p.Article

Ii-Key/HER-2/neu MHC class-II antigenic epitope vaccine peptide for breast cancerGILLOGLY, Michael E; KALLINTERIS, Nikoletta L; MINZHEN XU et al.Cancer immunology and immunotherapy. 2004, Vol 53, Num 6, pp 490-496, issn 0340-7004, 7 p.Article

Safety of yttrium-90 ibritumomab tiuxetan Radioimmunotherapy for relapsed low-grade, follicular, or transformed non-Hodgkin's lymphomaWITZIG, Thomas E; WHITE, Christine A; GORDON, Leo I et al.Journal of clinical oncology. 2003, Vol 21, Num 7, pp 1263-1270, issn 0732-183X, 8 p.Article

Clinical studies of vaccines targeting breast cancerKO, Byung K; KAWANO, Kouichiro; MURRAY, James L et al.Clinical cancer research. 2003, Vol 9, Num 9, pp 3222-3234, issn 1078-0432, 13 p.Article

Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancerRIVERA, Edgardo; VALERO, Vicente; HORTOBAGYI, Gabriel N et al.Journal of clinical oncology. 2001, Vol 19, Num 6, pp 1716-1722, issn 0732-183XArticle

Phase I-II vinorelbine (Navelbine®) by continuous infusion in patients with metastatic breast cancer : Cumulative toxicities limit dose escalationIBRAHIM, Nuhad K; VALERO, Vicente; BAST, Robert et al.Cancer investigation. 2001, Vol 19, Num 5, pp 459-466, issn 0735-7907Article

Monoclonal antibody treatment of solid tumors : A coming of ageMURRAY, James L.Seminars in oncology. 2000, Vol 27, Num 6, pp 64-70, issn 0093-7754, SUP11Conference Paper

Detection and Characterization of a Novel Subset of CD8⁺CD57⁺ T Cells in Metastatic Melanoma with an Incompletely Differentiated PhenotypeWU, Richard C; SHUJUAN LIU; LIZEE, Gregory et al.Clinical cancer research (Print). 2012, Vol 18, Num 9, pp 2465-2477, issn 1078-0432, 13 p.Article

Estrogen Receptor (ER) mRNA and ER-Related Gene Expression in Breast Cancers That Are 1% to 10% ER-Positive by ImmunohistochemistryIWAMOTO, Takayuki; BOOSER, Daniel; MATSUOKA, Junji et al.Journal of clinical oncology. 2012, Vol 30, Num 7, pp 729-734, issn 0732-183X, 6 p.Article

Identification of Cellular Proteins Required for Replication of Human Immunodeficiency Virus Type 1DZIUBA, Natallia; FERGUSON, Monique R; HODGE, Thomas W et al.AIDS research and human retroviruses. 2012, Vol 28, Num 10, pp 1329-1339, issn 0889-2229, 11 p.Article

Sensitivity of undifferentiated, high-TCR density CD8⁺ cells to methylene groups appended to tumor antigen determines their differentiation or deathKAWANO, Kouichiro; EFFERSON, Clay L; PEOPLES, George E et al.Cancer research (Baltimore). 2005, Vol 65, Num 7, pp 2930-2937, issn 0008-5472, 8 p.Article